2 more embarrassingly cheap dividend stocks I would buy

Here’s why Andy Ross thinks these two FTSE 100 (INDEXFTSE: UKX) companies could provide investors with impressive returns.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I recently looked at two dividend stocks that were showing a great combination of a low P/E and high dividend yield. Carrying on this research, it’s clear that they are far from being the only ones, as I’ve come across two other shares in the FTSE 100 that also have this potential winning combination.

Show me the money

Let me explain why I think the combination is usually such a good one. The low P/E means an investor gets the shares cheap, so there’s greater potential for future growth, and the high dividend means investors get income that can be used to live on, or even better, to buy more shares. The latter approach is known as compound investing and is a recognised way of building wealth.

Falling off a cliff?

But shares are cheap for a reason so let’s address the biggest issue facing my first pick, pharmaceutical company GlaxoSmithKline (LSE: GSK). It is the problem of drug patent expirations. On that front, progress is being made with 13 drugs currently going through trials at phase III, which is a late stage of development. In recent years there had been concern that pharma companies like GSK were facing a patent cliff, but the development of new blockbuster drugs could ease the pain.

The latest news from the company also provides some reassurance as the pivotal phase III CAPTAIN study of once-daily single inhaler triple therapy Trelegy Ellipta met its primary endpoint, a positive step on the path to getting onto pharmacy shelves. In April GSK also got approval for a two-drug medication in the US for the treatment of HIV. 

The signs are positive for the firm with Q1 turnover up 5% to £7.7bn, and operating profit up 10% to £1.4bn. Investors looking at the shares now would get them on a P/E of less than 13 which indicates good value, and on top of that, GSK offers great income potential as the dividend yield is a meaty 5.3%.

No crash landing

Airline easyJet (LSE: EZJ) is even cheaper than GSK, offering a larger yield of 5.6% and lower P/E ratio (under nine). How so? The latest trading update again flagged concerns around Brexit, but overall the numbers showed an airline that is doing well and has been preparing extensively for our EU exit. 

Although the company may be more cautious in its outlook, Q1 is likely to see good growth. In its April update, the airline stated that revenue is expected to grow by 7.3% with seat capacity growing by 14.5%, although costs are rising more quickly, which could hit future profits. FTSE 100 rival International Consolidated Airlines, which owns British Airways, has seen profits plunge, suggesting either that easyJet is doing better or that we can also expect it (in the short term) to be hit by issues of overcapacity and cost headwinds.

The concerns look to be factored into the price however, and I think easyJet is the better of these listed airline operators. Yes, there may be issues facing the industry, but I expect over the longer term that easyJet will be able to fly higher with its cheap prices, strong brand and range of popular destinations. Interim results out tomorrow will show more clearly the direction of travel. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Andy Ross has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »